Neil R Blacklow, University of Massachusetts, Worcester, Massachusetts, USA
Published online: January 2003
DOI: 10.1038/npg.els.0002242
Parvoviruses are small, species-specific DNA-containing viruses that infect several animal species. The human parvoviruses include two agents, B19 virus and adeno-associated virus; B19 virus causes several disease syndromes and is a medically important pathogen.
Keywords: parvovirus; B19 virus; erythema infectiosum
| References | |
| Anderson MJ, Higgins PG, Davis LR et al. (1985) Experimental parvoviral infection in humans. Journal of Infectious Diseases 152: 257–265. | |
| Bansal GP, Hatfield JA, Dunn FE et al. (1993) Candidate recombinant vaccine for human B19 parvovirus. Journal of Infectious Diseases 167: 1034–1044. | |
| book Blacklow NR (1988) "Adeno-associated viruses of humans". In: Pattison JR (ed.) Parvoviruses and Human Diseases, pp. 165–174. Boca Raton, FL: CRC Press | |
| Bostic JR, Brown KE, Young NS and Koenig S (1999) Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay. Journal of Infectious Diseases 179: 619–626. | |
| Brown KE, Hibbs JR, Gallinella G et al. (1994) Resistance to parvovirus B19 due to lack of virus receptor (erythrocyte P antigen). New England Journal of Medicine 330: 1192–1196. | |
| Deiss V, Tratschin JD, Weitz M and Siegl G (1990) Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Virology 175: 247–254. | |
| Kurtzman G, Frickhofen N, Kimball J et al. (1989) Pure red-cell aplasia of 10 years’ duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. New England Journal of Medicine 321: 519–523. | |
| Miller E, Fairley CK, Cohen BJ and Seng C (1998) Immediate and long term outcome of human parvovirus B19 infection in pregnancy. British Journal of Obstetrics and Gynaecology 105: 174–178. | |
| Plummer FA, Hammond GW, Forward K et al. (1985) An erythema infectiosum-like illness caused by human parvovirus infection. New England Journal of Medicine 313: 74–79. | |
| Siegl G and Cassinotti P (1998) Presence and significance of parvovirus B19 in blood and blood products. Biologicals 26: 89–94. | |
| Valeur-Jensen AK, Pedersen CB, Westergaard T et al. (1999) Risk factors for parvovirus B19 infection in pregnancy. JAMA 281: 1099–1105. | |
| Further Reading | |
| book Anderson LJ and Young NS (eds) (1997) "Human parvovirus B19". Monographs in Virology 20. | |
| Centers for Disease Control (1989) Risks associated with human parvovirus B19 infection. Morbidity and Mortality Weekly Report 38: 81–97. | |
| Harris JW (1992) Parvovirus B19 for the hematologist. American Journal of Hematology 39: 119–129. | |
| Morey AL, Keeling JW, Porter HJ and Fleming KA (1992) Clinical and histopathological features of parvovirus B19 infection in the human fetus. British Journal of Obstetrics and Gynaecology 99: 566–574. | |
| Naides SJ, Scharosch LI, Foto F and Howard EJ (1990) Rheumatologic manifestations of human parvovirus B19 infection in adults: initial two-year clinical experience. Arthritis and Rheumatism 33: 1297–1309. | |
Copyright © 2000-2013 by John Wiley & Sons, Inc., or related companies. All rights reserved.
